Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc operates in various business sectors.
Amphastar Pharmaceuticals Inc (29A) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: 0.097x
Based on the latest financial reports, Amphastar Pharmaceuticals Inc (29A) has a cash flow conversion efficiency ratio of 0.097x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€69.11 Million) by net assets (€713.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Amphastar Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2018–2023)
This chart illustrates how Amphastar Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Amphastar Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amphastar Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BioAdaptives Inc
PINK:BDPT
|
0.103x |
|
Focus Home Interactive Société anonyme
STU:0HF
|
0.011x |
|
Sparindex INDEX Europa Forsvar
CO:SPIIEF
|
N/A |
|
NHK SPRING (NHK.SG)
STU:NHK
|
N/A |
|
ROLLS-ROYCE HLDGS
MU:RRU
|
N/A |
|
Wealth Invest AKL AlphaCura 0/50/100 W
CO:WEIACW
|
N/A |
|
R STAHL N
BE:RSL2
|
-0.003x |
|
MEDION
MU:MDN
|
N/A |
Annual Cash Flow Conversion Efficiency for Amphastar Pharmaceuticals Inc (2018–2023)
The table below shows the annual cash flow conversion efficiency of Amphastar Pharmaceuticals Inc from 2018 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €639.42 Million | €183.50 Million | 0.287x | +70.12% |
| 2022-12-31 | €528.66 Million | €89.18 Million | 0.169x | -23.30% |
| 2021-12-31 | €445.52 Million | €97.99 Million | 0.220x | +72.35% |
| 2020-12-31 | €448.72 Million | €57.27 Million | 0.128x | +116.38% |
| 2019-12-31 | €427.53 Million | €25.21 Million | 0.059x | -43.73% |
| 2018-12-31 | €364.36 Million | €38.19 Million | 0.105x | -- |